跳至主要内容
临床试验/NCT02152514
NCT02152514终止4 期

Randomized Controlled Trial Comparing Post-VATS Analgesia Between Patients With an Intrathecal Injection of Morphine and Sufentanil Versus Placebo.

Université de Sherbrooke1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
34
试验地点
1
主要终点
Hydromorphone consommation

研究概览

简要总结

The purpose of the study is to determine if the administration of a mix of Sufentanil and Morphine in intrathecal is a better analgesia regimen than PCA alone in patient post-VATS.

详细描述

This study will compare the need for analgesia (Hydromorphone PCA) of two groups of patients post-VATS. The placebo group will only have a PCA for post-operative analgesia, witch is the standard care for patient post-VATS. The experimental group will have a intrathecal injection of a mix of morphine and sufentanil before the induction of anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA 1,2 or 3
  • Minimum weight of 50 kg
  • Patient able to consent

排除标准

  • Patient refusal
  • Patient unable to understand PCA
  • Contraindication to rachianalgesia
  • Pregnancy
  • Over 30 mg of morphine during the last 24 hours
  • Use of Pregabalin, Gabapentin, Doluxetin, Amitriptyline or NSAI in a context of chronic pain
  • Severe allergic reaction to morphine, hydromorphone, sufentanil or local anesthetic
  • Intubation over 1 hour after surgery (unability to use PCA)
  • High risk of conversion to thoracotomy
  • Unable to perform rachianalgesia due to technical difficulties

研究组 & 干预措施

Intrathecal Morphine/Sufentanil and PCA

Active Comparator

Patients will receive an intrathecal injection of Morphine 250 mcg and Sufentanil 10 mcg before the induction of anesthesia. They will have a PCA for analgesia rescue in the post-operative period.

干预措施: Intrathecal Morphine/Sufentanil (Drug)

Intrathecal Morphine/Sufentanil and PCA

Active Comparator

Patients will receive an intrathecal injection of Morphine 250 mcg and Sufentanil 10 mcg before the induction of anesthesia. They will have a PCA for analgesia rescue in the post-operative period.

干预措施: PCA (Device)

PCA alone

Placebo Comparator

Patients will NOT receive an intrathecal injection of Morphine 250 mcg and Sufentanil 10 mcg before the induction of anesthesia. They will only have a PCA for analgesia in the post-operative period.

干预措施: PCA (Device)

结局指标

主要结局

Hydromorphone consommation

时间窗: 24hr

The amount of Hydromorphone needed by the patient in the first 24hr after his VATS.

次要结局

  • Adverse reactions of narcotics(24hr)
  • Adverse effects of narcotics(Every 4h x 24hr)
  • Pain(Every 4h x 24hr)
  • Adverse reactions associate with rachianesthesia(24hr)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanick Sansoucy

Anesthesiologist

Université de Sherbrooke

研究点 (1)

Loading locations...

相似试验